NNOX peer analysis
Nano-X Imaging (NNOX) against its competitors: price, today's move, 1-year return and market value side by side.
NNOX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| CATX Perspective Therapeutics | $0.79 | -7.64% | -61.50% | $98.00M |
| HCAT Health Catalyst | $1.51 | 3.42% | -50.68% | $111.19M |
| HSDT Solana | $1.92 | -0.52% | -63.79% | $125.65M |
| INGN Inogen | $6.01 | -1.72% | -13.66% | $161.09M |
| MXCT MaxCyte | $1.16 | -10.77% | -11.56% | $134.17M |
| OM Outset Medical | $4.12 | -2.60% | -64.18% | $79.83M |
| PROF Profound Medical | $7.70 | 4.90% | 25.30% | $268.47M |
| QTRX Quanterix | $3.29 | -2.66% | -32.26% | $159.85M |
| SNWV SANUWAVE Health | $1.85 | -15.53% | -91.71% | $18.84M |
| TLSI TriSalus Life Sciences | $3.22 | -0.92% | -25.97% | $200.12M |
| NNOX Nano-X Imaging | $0.41 | 76.37% | -92.60% | $18.36M |
- NNOX's peers: CATX (Perspective Therapeutics), HCAT (Health Catalyst), HSDT (Solana), INGN (Inogen), MXCT (MaxCyte), OM (Outset Medical), PROF (Profound Medical), QTRX (Quanterix).
Updated 2026-11-11 06:45 UTC